BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication: Hepatic disease

...borate (2APB) decreased liver damage and increased survival compared with vehicle control. Next steps by Heprotech Inc....
...toxicity, page 5). SciBX 5(5); doi:10.1038/scibx.2012.125 Published online Feb. 2, 2012 Findings patented; licensed to Heprotech...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication

...borate (2APB) decreased liver damage and increased survival compared with vehicle control. Next steps by Heprotech Inc....
...toxicity, page 5). SciBX 5(5); doi:10.1038/scibx.2012.125 Published online Feb. 2, 2012 Findings patented; licensed to Heprotech...
BioCentury | Feb 2, 2012
Targets & Mechanisms

Closing the gap on liver toxicity

...gap junction inhibitor that protects mice from drug-induced liver toxicity. 1 The team has founded Heprotech Inc....
...University College London . The findings in the paper are covered by patents licensed to Heprotech...
...Institutions Mentioned CoDa Therapeutics Inc. , San Diego, Calif. Harvard Medical School , Boston, Mass. Heprotech Inc....
Items per page:
1 - 3 of 3
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication: Hepatic disease

...borate (2APB) decreased liver damage and increased survival compared with vehicle control. Next steps by Heprotech Inc....
...toxicity, page 5). SciBX 5(5); doi:10.1038/scibx.2012.125 Published online Feb. 2, 2012 Findings patented; licensed to Heprotech...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication

...borate (2APB) decreased liver damage and increased survival compared with vehicle control. Next steps by Heprotech Inc....
...toxicity, page 5). SciBX 5(5); doi:10.1038/scibx.2012.125 Published online Feb. 2, 2012 Findings patented; licensed to Heprotech...
BioCentury | Feb 2, 2012
Targets & Mechanisms

Closing the gap on liver toxicity

...gap junction inhibitor that protects mice from drug-induced liver toxicity. 1 The team has founded Heprotech Inc....
...University College London . The findings in the paper are covered by patents licensed to Heprotech...
...Institutions Mentioned CoDa Therapeutics Inc. , San Diego, Calif. Harvard Medical School , Boston, Mass. Heprotech Inc....
Items per page:
1 - 3 of 3